Insider Transaction of Vivaldi Coelho Rogerio at Crinetics Pharmaceuticals, Inc.

Vivaldi Coelho Rogerio, a director at Crinetics Pharmaceuticals, Inc. (CRNX), reported a sale of 3,000 shares of Common Stock on July 2, 2026. The shares were sold at a price of $40.00 per share, totaling $120,000. This transaction was executed automatically as part of a Rule 10b5-1 trading plan adopted on December 11, 2025. Following this sale, Rogerio directly owns 19,225 shares of the company's common stock. The filing, marked as Form 4, was signed on July 7, 2026.